Navigation Links
Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads
Date:9/22/2010

Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads -- BERGISCH GLADBACH, Germany, September 22, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services Click to view news release full screen  

Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads

 

BERGISCH GLADBACH, Germany, September 22, 2010 /PRNewswire/ -- Miltenyi Biotec announces the worldwide first and exclusive release of the Anti-GLAST (ACSA-1) MicroBead Kit. Isolation of viable GLAST-expressing astrocytes is now possible within one hour using the first commercially available antibody against an extracellular surface epitope of GLAST. Magnetic cell separation with MACS(R) Technology is the method of choice for the specific isolation of viable cells. A prerequisite for specific cell isolation is the availability of antibodies directed against a specific cell surface antigen. Suitable antibodies against extracellular markers on the astrocyte cell surface were not available until recently, and astrocytes had to be isolated by time-consuming methods, such as generation of astrocyte cultures, which even differ considerably from astrocytes in vivo, or by transgenic approaches.

The new anti-GLAST (ACSA-1) antibody (astrocyte cell surface antigen 1; ACSA-1) recognizes an extracellular epitope of the astrocyte-specific glutamate transporter GLAST (EAAT1), and it shows specific and sensitive labeling of GLAST-positive cells in flow cytometry, immunohistochemistry, and immunocytochemistry.

"The Anti-GLAST (ACSA-1) MicroBead Kit provides the first tool for the straightforward isolation of astrocytes from dissociated brain tissue, and enables the separation of astrocytes based on their expression of GLAST," says Dr. Melanie Jungblut, the responsible R&D Project Manager. "The kit allows for the direct isolation of viable primary astrocytes within one hour, and achieves high purity by minimizing contamination by other cells."

The Anti-GLAST (ACSA-1) MicroBead Kit is exclusively available from Miltenyi Biotec.

About Miltenyi Biotec

Miltenyi Biotec's company mission is to improve scientific understanding and medical progress by providing products and services for cellular therapies. More than 1,100 employees worldwide develop, produce and sell products for biomedical research and clinical applications. The renowned MACS Technology for magnetic separation of cells has become a standard technology in research laboratories worldwide.

Press contact: Prof. Dr. Uwe A. O. Heinlein Corporate Communications, Miltenyi Biotec GmbH Friedrich-Ebert-Strasse 68, 51429 Bergisch Gladbach, Germany Phone: +49-2204-8306-6590 E-mail: uweh@miltenyibiotec.de .
'/>"/>

SOURCE Miltenyi Biotec GmbH
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
2. Directors Forum: PEPFAR and the Global AIDS Response
3. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
4. West Pharmaceutical Services, Inc. Appoints New Director
5. Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
6. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
7. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
8. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
9. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
10. PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
11. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016 --> ... report "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible ... Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020", ... over the forecast period of 2015 to 2020. The ... at CAGR of 10.5% from 2015 to 2020. ...
(Date:2/8/2016)... , Feb. 8, 2016 ... that formerly specialized in the development of ... announced that it has divided its interests ... While Nueterra Capital will continue the founding ... NueHealth will operate a national system of ...
(Date:2/8/2016)... Feb. 8, 2016  A research team led by ... discovered details of how the abnormal breakage and rearrangement ... aggressive form of acute lymphoblastic leukemia (ALL). Such leukemias ... mutations trigger overproduction of immature cells, called lymphoblasts. ... of the malfunction underlying the type called "Ph-like ALL" ...
Breaking Medicine Technology:
(Date:2/8/2016)... , ... February 08, 2016 , ... ... in Houma, LA, celebrates the beginning of a new charity campaign. As part ... Court Appointed Special Advocates (CASA). In the belief that children deserve a voice, ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... BantamPro L top-load case packer for pouches, bags, and flow wrapped products at ... help co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case ...
(Date:2/8/2016)... Island, SC (PRWEB) , ... February 08, 2016 , ... ... surrounding areas with a vital new community enrichment program, has teamed up with Citizens ... women and children suffering from intimate abuse. To support all those victimized by the ...
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... Delta ... $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired as ... was the American Cancer Society’s 2015 CEO of the Year , helped lead ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders and ... number of women and men with eating disorders report a history of trauma, ... the development of an eating disorder. , At the 2016 iaedp Symposium, ...
Breaking Medicine News(10 mins):